Autor: |
Fitzgerald JT; Department of Chemistry, Stanford University, Stanford, California 94305, USA., Charkoudian LK, Watts KR, Khosla C |
Jazyk: |
angličtina |
Zdroj: |
Journal of the American Chemical Society [J Am Chem Soc] 2013 Mar 13; Vol. 135 (10), pp. 3752-5. Date of Electronic Publication: 2013 Mar 04. |
DOI: |
10.1021/ja311579s |
Abstrakt: |
A-74528 is a C30 polyketide natural product that functions as an inhibitor of 2',5'-oligoadenylate phosphodiesterase (2'-PDE), a key regulatory enzyme of the interferon pathway. Modulation of 2'-PDE represents a unique therapeutic approach for regulating viral infections. The gene cluster responsible for biosynthesis of A-74528 yields minute amounts of this natural product together with considerably larger quantities of a structurally dissimilar C30 cytotoxic agent, fredericamycin. Through construction and analysis of a series of knockout mutants, we identified the genes necessary for A-74528 biosynthesis. Remarkably, the formation of six stereocenters and the regiospecific formation of six rings in A-74528 appear to be catalyzed by only two tailoring enzymes, a cyclase and an oxygenase, in addition to the core polyketide synthase. The inferred pathway was genetically refactored in a heterologous host, Streptomyces coelicolor CH999, to produce 3 mg/L A-74528 in the absence of fredericamycin. |
Databáze: |
MEDLINE |
Externí odkaz: |
|